Conference Coverage

Ultraprocessed Foods Associated With Relapse Risk in Crohn’s Disease


 

FROM UEG 2024

The highest associations with relapse were in the subgroup of bread, pastries, and starch (HR, 3.37; 95% CI, 1.26-8.25) and the subgroup of oils and spreads (HR, 2.76; 95% CI, 1.02-7.45).

“The selection of healthy food is highly important, especially since we know that certain food ingredients can contribute to the pathogenesis of CD,” Shabat said. Patients can use partial enteral nutrition to provide 40%-50% of daily caloric intake in order to maintain remission, but she acknowledged it can be really difficult to adhere to.

She concluded by asserting that the study results, along with future research, should contribute to establishing nutritional guidelines to reduce UPF consumption in patients with CD in order to maintain remission.

Commenting on the study, Kevin Whelan, PhD, professor of dietetics and head of the Department of Nutritional Sciences at King’s College London in England, said that he was intrigued by the subgroup analysis that showed breads, pastries, oils, and spreads as having the strongest association with relapse risk.

He also remarked that these foods almost ubiquitously contain emulsifiers, and so the association might have less to do with UPFs in general and more to do with emulsifiers.

Concurring, Shabat noted that, while emulsifiers can negatively influence the microbiota and the gut barrier function, as well as contribute to intestinal inflammation, further mechanistic studies are required to understand these effects.

We need to determine if all additives have the same effect on the inflammatory process and also need studies looking at UPFs alone, she added.

Shabat reported receiving personal fees from Nestle Health Science (Wolfson Medical Center IP) for consulting and speaking and from Takeda and Ferring for speaking. Whelan reported no relevant disclosures.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

FDA Approves Skyrizi for Ulcerative Colitis
MDedge Internal Medicine
A Fitbit for the Gut May Aid in Detection of GI Disorders
MDedge Internal Medicine
Environment More Than Genes Affects Age of IBD Diagnosis
MDedge Internal Medicine
Top-Down Treatment Appears Better for Patients With Crohn’s Disease
MDedge Internal Medicine
New Associations Identified Between IBD and Extraintestinal Manifestations
MDedge Internal Medicine
Environmental Pollutants Play a Growing Role in IBD
MDedge Internal Medicine
In Crohn’s Disease, Early Anti-TNF Levels May be Crucial
MDedge Internal Medicine
New Biologic Tulisokibart Beats Placebo in Ulcerative Colitis Trial
MDedge Internal Medicine
FDA Approves Ustekinumab Biosimilar Otulfi
MDedge Internal Medicine
GI Docs Will Need to Forge a ‘Human-Computer Cooperative’
MDedge Internal Medicine